-
November 21, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently gave ...
-
November 21, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news with the ...
-
November 21, 2012
Pfizer Inc. (PFE) recently announced positive top-line data on its once-daily formulation of Lyrica (pregabalin). ...
-
November 19, 2012
Pfizer Inc. (PFE) recently presented disappointing top-line data from a phase III study that was conducted to ...
-
November 15, 2012
Another drug in Pfizer's (PFE) portfolio started facing generic competition recently. Generic competition for ...
-
November 15, 2012
Celgene Corporation (CELG) recently announced encouraging results on its candidate apremilast from a phase III study ...
-
November 14, 2012
Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced positive data on its pipeline ...
-
November 13, 2012
The European Commission (EC) recently approved Swiss pharmaceutical giant Novartis' (NVS) Votubia to treat adults ...
-
November 13, 2012
Medivation Inc. (MDVN) reported a third quarter loss of 6 cents per share, narrower than the Zacks Consensus ...
-
November 08, 2012
Auxilium Pharmaceuticals, Inc. (AUXL) reported a loss of 21 cents per share in the third quarter of 2012, wider than ...
-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
-
November 07, 2012
Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
-
November 05, 2012
Isis Pharmaceuticals Inc. (ISIS) recently announced that Pfizer Inc. (PFE) will move EXC 001 (also known as as ...
-
November 05, 2012
Teva has restructuring and growth opportunities, but the risk is still elevated.
-
November 02, 2012
Benchmarks finished in the green on the first trading day of November banking on positive consumer confidence and ...
-
November 01, 2012
Pfizer Inc. (PFE) posted third quarter earnings of 53 cents per share, a penny above the Zacks Consensus Estimate ...
-
November 01, 2012
GlaxoSmithKline (GSK) reported third quarter 2012 earnings of 71 cents per American Depository Share (ADS), well ...
-
November 01, 2012
We have a flood of economic and earnings reports this morning, but the focus will be on the labor market today ahead ...
-
November 01, 2012
Thursday, November 1, 2012 We have a flood of economic and earnings reports this morning, but the focus will be ...
-
November 01, 2012
Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global ...
